Combined therapy with sitagliptin plus granulocyte-colony stimulating factor in patients with acute myocardial infarction — Long-term results of the SITAGRAMI trial
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference30 articles.
1. Granulocyte colony stimulating factor therapy for acute myocardial infarction;Moazzami;Cochrane Database Syst. Rev.,2013
2. Autologous Bone Marrow Stem Cell Mobilization Induced by Granulocyte Colony-Stimulating Factor After Subacute ST-Segment Elevation Myocardial Infarction Undergoing Late Revascularization
3. Stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute myocardial infarction. Long-term results of the REVIVAL-2 trial;Steppich;Thromb. Haemost.,2016
4. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction;Zaruba;Cell Stem Cell,2009
5. Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction;Theiss;Int. J. Cardiol.,2013
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cell-Free Treatments: A New Generation of Targeted Therapies for Treatment of Ischemic Heart Diseases;CELL J;2022
2. Cardiovascular Effects of Incretin-Based Therapies: Integrating Mechanisms With Cardiovascular Outcome Trials;Diabetes;2022-01-11
3. Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis;Cochrane Database of Systematic Reviews;2021-10-25
4. Bispecific Antibody Inhalation Therapy for Redirecting Stem Cells from the Lungs to Repair Heart Injury;Advanced Science;2020-11-19
5. “Protocol for a phase 2, randomized, double-blind, placebo-controlled, safety and efficacy study of dutogliptin in combination with filgrastim in early recovery post-myocardial infarction”: study protocol for a randomized controlled trial;Trials;2020-08-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3